solvent resulted in a rapid (, 30 min) cis-selective cyclisation
(85 : 15) producing c-lactams 1 and 5 in excellent yield (90%)
(Table 1, entry 3). The cis-relationship of the vinyl and
p-methoxybenzyl groups was assigned unambiguously from the
observation of NOE interactions between H-4 and H-5. With
TTMPP as the ligand, use of solvents other than MeCN resulted
in either lower selectivity or unviably slow reactions, even at
elevated temperatures. A range of other phosphines in conjunction
with MeCN were investigated for the cyclisation (entries 5–9),
but no increase in selectivity was observed. Interestingly, only
with TTMPP in MeCN did the reaction proceed at room
temperature.
Table 2 Palladium-catalysed cyclisation of 2 and 7a–d
Entry Substrate
cis : trans ratioa Isolated yield
R
1
2
3
4
5
a
2
CH2ArOMe 85 : 15
90%
7a
7b
7c
7db
Me
i-Pr
86 : 14
67 : 33
90 : 10
83 : 17
90%
78%
85%
79%
CH2i-Pr
n-Bu
Determined by 1H NMR analysis of the crude product and NOE
b
or NOESY experiments. Racemic substrate.
With the conditions optimised for the synthesis of 4,5-cis-
c-lactam 1 from substrate 2, we wished to investigate the generality
of the procedure for other amino acid-derived substrates 7a–d, and
in particular the effect of the steric bulk of R on the selectivity of
the cyclisation (Scheme 2). The required substrates were synthe-
sised from L-alanine, L-valine, L-leucine and DL-norleucine
respectively via an adaptation of the route used for 2. Thus, the
N-tosylamino acids were reduced with LiAlH4 and then subjected
to Swern oxidation and Wittig homologation. The resulting
unsaturated esters were reduced with DIBAL-H, desulfonylated
and the crude amines then subjected to reductive amination to give
secondary amines 6a–d. Amines 6a–d were coupled with tosylacetic
acid using PyBOP,8 and the resulting allylic alcohols carboxy-
methylated under standard conditions to give the desired
cyclisation substrates 7a–d. All steps proceeded in good to
excellent yield for all substrates.
Fig. 1 Proposed model for cis diastereoselectivity of the cyclisation.
preferred reactive conformation 9, where the palladium and its
associated ligands avoid unfavourable interactions with the R
group. As a linear relationship between the size of the R group and
the selectivity of the reaction was not observed, it is assumed that
there are other factors controlling the selectivity. For example, a
1,3-diaxial interaction between R and the enolate oxygen and/or
H1 might be considered in addition to the Pd–R interaction
(Fig. 1).
The allylic carbonates 7a–d were subjected to the conditions
optimised for substrate 2 (entry 3, Table 1; entry 1, Table 2).{ All
substrates underwent facile cis-selective cyclisation (Table 2). The
cis-diastereoselectivity of the cyclisation may be explained by the
In conclusion, we have developed a new method for the
efficient, diastereoselective synthesis of cis-4,5-disubstituted
c-lactams through the Pd(0)-catalysed cyclisation of a-tosyl-
substituted amides. These are the first examples of such
cyclisations to be carried out on acyclic substrates having this
level of complexity,2 and the substrates are readily synthesised as
single enantiomers using routine transformations starting from
a-amino acids. A model to explain the observed stereoselectivity
has been proposed. In addition, the highly functionalised nature of
c-lactams 1 and 8a–d render them amenable to further substitu-
tion. For example, 1 undergoes alkylation of the derived sulfone-
substituted enolate on the less hindered face with complete
stereoselectivity to provide 10 in good yield (Scheme 3).
The authors thank EPSRC and Knoll Pharmaceuticals
(CASE studentship to C. J. T. H.) and GlaxoSmithKline for
support.
Scheme 2 Reagents and conditions: (i) LiAlH4 (3.0 equiv.), THF, reflux,
2 h; (ii) (a) (COCl)2 (1.2 equiv.), DMSO (2.4 equiv.), CH2Cl2, 278 uC,
45 min; (b) Et3N (5 equiv.), rt, 10 min; (iii) Ph3PCHCO2Et (4 equiv.),
CH2Cl2, rt, 12 h; (iv) DIBAL-H (3.6 equiv.), CH2Cl2, 278 uC, 15 min,
then rt, 2 h; (v) NH3 (l), Na (6 equiv.), 278 uC; (vi) (a) 4-methylbenzalde-
˚
hyde (2 equiv.), MeOH, 4 A MS, 12 h, rt; (b) NaBH4 (2.4 equiv.), 0 uC–rt,
1 h; (vii) DCC (2.1 equiv.), HOBt (2.1 equiv.), TsCH2CO2H (2 equiv.),
CH2Cl2, rt, 12 h or PyBOP (2 equiv.), Hu¨nig’s base (5.5 equiv.),
TsCH2CO2H (2 equiv.), CH2Cl2, rt, 12 h; (viii) methyl chloroformate
(2 equiv.), pyridine (2 equiv.), DMAP (cat.), CH2Cl2, 1 h.
Scheme 3 Reagents and conditions: KH (1.1 equiv.), prenyl bromide
(10 equiv.), DMF, 0 uC, 30 min, 78%.
3440 | Chem. Commun., 2005, 3439–3441
This journal is ß The Royal Society of Chemistry 2005